FindTrial
Sign In

Simultaneous core needle biopsy and radiofrequency ablation in lung cancer guided by rapid on-site evaluation

Simultaneous core needle biopsy and Radiofrequency Ablation in Lung Cancer guided by rapid on-site evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020531
Enrollment
Unknown
Registered
2019-01-06
Start date
2019-01-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Gold Standard:simultaneous core needle biopsy
Index test:rapid&#32
on-site&#32
evaluation

Sponsors

Tengzhou Central People's Hospial, Affiliated Hospital of Jining Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. suspicious lung cancer with pulmonary nodules; 2. Can not tolerate general anesthesia surgery; 3. do not want to undergo surgical treatment

Exclusion criteria

Exclusion criteria: 1. Cancer can not be ablated; 2. The patient's body is extremely poor and can not tolerate puncture; 3. Abnormal coagulation, poor cardiopulmonary function and so on.

Design outcomes

Primary

MeasureTime frame
accuracy;Complications;—

Countries

China

Contacts

Public ContactZhao Shouhua

Tengzhou Central People's Hospial, Affiliated Hospital of Jining Medical University

zsh75@163.com+86 13616327655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026